Astellas Pharma US

Astellas Pharma US is a biopharmaceutical company committed to developing and providing access to innovative medicines that address unmet medical needs. The company emphasizes the importance of research and development, supports clinical trials, and advocates for policies that balance affordability with continued innovation. It operates in the United States, with a focus on diseases such as cancer, neurological disorders, rare diseases, and chronic illnesses. The organization engages in policy advocacy, collaborates with partners, and maintains a focus on patient support and education. It has a corporate social responsibility program, and actively participates in sustainability initiatives. The company’s leadership includes executives such as Joe Devaney, Shontelle Dodson, Lynn Fenicchia, Moyra Knight, Mark Reisenauer, and Steve Sabus. It maintains a website, social media presence, and provides resources for patients, healthcare providers, and researchers.